SEC Form 4 · accession 0001177648-18-000051
ENANTA PHARMACEUTICALS INC · ENTA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Tim Ocain
Officer — Senior Vice President
Period of report
Dec 3, 2018
Accepted (ET)
Dec 4, 2018 · 5:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001177648
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 3, 2018 | M | 2,000 | $32.27 | A | 8,127 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $32.27 | Dec 3, 2018 | M | 2,000 | D | — | Jan 30, 2024 | Common Stock | 2,000 | 58,000 | D |
Explanation of responses
- F1100% of the shares subject to this option are fully vested and exercisable.